Paradigm Biocapital Advisors LP - 21 Aug 2025 SCHEDULE 13G Report for Agios Pharmaceuticals, Inc. Common Stock, $0.001 par value per share (AGIO)

Filing Manager: Paradigm Biocapital Advisors LP
Reporting Manager: Paradigm BioCapital Advisors LP
Security: Agios Pharmaceuticals, Inc. Common Stock, $0.001 par value per share
Symbol: AGIO
Shares outstanding: 58.2M shares
Disclosed Ownership: 3.03M shares
Ownership: 5.2%
Form type: SCHEDULE 13G
Filing time: 28 Aug 2025, 16:31:10 UTC
Date of event: 21 Aug 2025
Next filing: 14 Nov 2025
SEC: View on sec.gov

Reporting Managers (4)

Name	Ownership	Shares Owned	sole voting power	Signature	Title
Paradigm BioCapital Advisors LP	5.2%	3.03M	3.03M	/s/ David K. Kim	David K. Kim / Authorized Signatory
Paradigm BioCapital Advisors GP LLC	5.2%	3.03M	3.03M	/s/ David K. Kim	David K. Kim / Authorized Signatory
Senai Asefaw, M.D.	5.2%	3.03M	3.03M	/s/ Senai Asefaw, M.D.	N/A
Paradigm BioCapital International Fund Ltd.	4.6%	2.67M	2.67M	David K. Kim / Authorized Signatory	N/A